Betamethasone Acetate and Sodium Phosphate Injection

20 April 2009

Products Affected - Description

Celestone Soluspan 6 mg/mL injectable suspension (betamethasone acetate and betamethasone sodium phosphate)
5 mL vials (NDC 00085-0566-05), Schering

Reason for the Shortage

Schering states Celestone Soluspan was being allocated due to increased demand for product.

Estimated Resupply Dates

Schering has Celestone Soluspan injectable suspension (NDC 00085-0566-05) readily available.

Related Shortages

• Fluticasone Propionate HFA Inhaler— Resolved
• Hydrocortisone Sodium Succinate— Resolved
• Methylprednisolone Acetate Injection— Resolved
• Methylprednisolone Sodium Succinate
• Prednisolone Tablets— Resolved
• Triamcinolone Injection— Resolved

Updated

April 20, 2009; February 23, 2009; January 6, 2009; November 12, 2008; September 22, 2008; September 10, 2008, University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.

Back to Drug Shortage Product Bulletins